Start Low, Go Slow, but Don’t Go This Way yet

Adventitial Vasa Vasorum: A Potential Therapeutic Target But Yet a Long Way to Go

Correspondence To the Editor: I reviewed the article Quantification of adventitial vasa vasorum (VV) vascularization in double‑injury restenotic arteries by Meng et al. with great interest, which described their experiment about adventitial VV and postangioplasty restenosis. Percutaneous transluminal angioplasty is now widely used for the treatment of atherosclerotic lesions in various arteries...

New classification of membranoproliferative glomerulonephritis: a good start but a long way to go

As with other primary glomerulonephritis, pathologic diagnosis of membranoproliferative glomerulonephritis (MPGN) is based on characteristic histologic findings such as mesangial and endocapillary proliferation accompanied by thickening of the glomerular basement membrane (GBM) frequently demonstrating “double contour” due to the interposition of mesangium and infiltration of mononuclear cells ...

Making progress, but still a way to go.

Progress, but still a long way to go.

Management of atrial tachyarrhythmias, especially atrial fibrillation (AF), in patients with congestive heart failure (CHF) remains a major challenge. It is widely recognized that CHF promotes AF and that AF worsens CHF. An individual with either condition who develops the other has higher morbidity and poorer prognosis. The prevalence of AF and CHF is expected to increase as the population age...

Monte Carlo Go Has a Way to Go

Monte Carlo Go is a promising method to improve the performance of computer Go programs. This approach determines the next move to play based on many Monte Carlo samples. This paper examines the relative advantages of additional samples and enhancements for Monte Carlo Go. By parallelizing Monte Carlo Go, we could increase sample sizes by two orders of magnitude. Experimental results obtained i...